Israel Active

A study by Tel Aviv University reveals how plasmids - small circular DNA fragments - neutralize bacterial defense mechanisms. It opens a door to combating antibiotic resistance. Plasmids could also break down pollutants, fix carbon dioxide, and improve gut bacteria.

At the Shamir Medical Center, hyperbaric oxygen therapy (HBOT) - breathing pure oxygen in pressurized chambers - is proving to be a game-changer for Post Traumatic Stress Disorder (PTSD) sufferers, with 70% reporting lasting relief. See previously.

Tel Aviv University researchers have developed bio-degradable nanoparticles to simultaneously deliver two chemicals to tumors that express the P-Selectin protein. The dual combination needs to arrive at the same time to be most effective.

Researchers from Jerusalem's Hebrew University and Edinburgh  University, Scotland, uncovered how critical proteins, called transcription factors (TFs), define cellular identity. It raises the possibility of converting skin cells into heart cells, or insulin-producing cells to cure diabetes.

Israel’s United Hatzalah first responder organization has implemented an Artificial Intelligence system developed by the IDF 8200 intelligence unit. It analyzes 18 years of historical emergency data and in trials has achieved a 85% accuracy rate in predicting locations and times of emergency events.

A consortium led by Prof. Hossam Haick of Israel’s Technion Institute has secured an eight million Euros grant from the European Union, for early diagnosis and monitoring of schizophrenia. The VOLABIOS project will analyze biomarkers derived from various sources in the body.

The UK Government’s G-Cloud 14 framework now includes the clinical decision-support software platform from Israel’s Seegnal eHealth (see previously). UK NHS trusts, hospitals, and clinics can now easily procure Seegnal's "Virtual Digital Pharmacist".

PixCell Medical (see previously) has achieved EU certification for its HemoScreen Complete Blood Count (CBC) analyzer. It is the first such device to pass the new, strict, European In Vitro Diagnostic Medical Devices Regulation (IVDR). It already is US-approved.

A study led by Hebrew University of Jerusalem’s  Dr. Ido Goldstein has discovered that repeated fasting (e.g. on alternate days) triggers a cellular memory mechanism in the liver, improving its response to future fasting events, offering new insights into metabolic regulation.

Researchers from the Hebrew University of Jerusalem, Israel’s Weizmann Institute and the University of Tokyo have created the peptide D’20 that  targets and inhibits an enzyme called Matrix Metallopeptidase 7 (MMP7). MMP7 helps cancer cells invade surrounding tissues.